BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2050925)

  • 1. Effect of superoxide dismutase on infarct size and postischemic recovery of myocardial contractility and metabolism in dogs.
    Vanhaecke J; Van de Werf F; Ronaszeki A; Flameng W; Lesaffre E; De Geest H
    J Am Coll Cardiol; 1991 Jul; 18(1):224-30. PubMed ID: 2050925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow.
    Przyklenk K; Kloner RA
    Circ Res; 1989 Jan; 64(1):86-96. PubMed ID: 2909304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue-type plasminogen activator ameliorates ischemic derangements induced by thrombotic occlusion in closed chest anesthetized dogs.
    Egashira K; Kawai K; Nagano M; Sakuma A; Nakamura M; Tomoike H
    J Am Coll Cardiol; 1992 Jul; 20(1):218-25. PubMed ID: 1607528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs.
    Nejima J; Knight DR; Fallon JT; Uemura N; Manders WT; Canfield DR; Cohen MV; Vatner SF
    Circulation; 1989 Jan; 79(1):143-53. PubMed ID: 2910539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.
    Chi LG; Tamura Y; Hoff PT; Macha M; Gallagher KP; Schork MA; Lucchesi BR
    Circ Res; 1989 Apr; 64(4):665-75. PubMed ID: 2702730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs.
    Uraizee A; Reimer KA; Murry CE; Jennings RB
    Circulation; 1987 Jun; 75(6):1237-48. PubMed ID: 3568330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts.
    Villari B; Ambrosio G; Golino P; Ragni M; Focaccio A; Tritto I; Salvatore M; Chiariello M
    Am Heart J; 1993 Jan; 125(1):11-23. PubMed ID: 8417506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart.
    Tamura Y; Chi LG; Driscoll EM; Hoff PT; Freeman BA; Gallagher KP; Lucchesi BR
    Circ Res; 1988 Nov; 63(5):944-59. PubMed ID: 3180357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of human recombinant superoxide dismutase on canine myocardial infarction.
    Patel BS; Jeroudi MO; O'Neill PG; Roberts R; Bolli R
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H369-80. PubMed ID: 2309904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced myocardial salvage by combined treatment with recombinant single-chain urokinase-type plasminogen activator and recombinant human superoxide dismutase in a canine coronary thrombosis model.
    Fincke U; Schneider J; Friderichs E; Giertz H; Flohé L
    Arzneimittelforschung; 1988 Jan; 38(1):138-42. PubMed ID: 3365272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide dismutase plus catalase therapy delays neither cell death nor the loss of the TTC reaction in experimental myocardial infarction in dogs.
    Tanaka M; Richard VJ; Murry CE; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 1993 Apr; 25(4):367-78. PubMed ID: 8340930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Limitation of myocardial infarct size by polyethylene glycol-conjugated superoxide dismutase in a canine model of 90 min coronary occlusion followed by 4 days of reperfusion].
    Tamura Y; Saito S; Hatano M; Lucchesi BR
    Kokyu To Junkan; 1989 Feb; 37(2):201-8. PubMed ID: 2727408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of superoxide dismutase administered by coronary sinus retroperfusion on ischemic reperfused canine heart].
    Uriuda Y; Hatori N; Okuda E; Yoshizu H; Tanaka S
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Jan; 41(1):7-15. PubMed ID: 8459148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide dismutase plus catalase improve contractile function in the canine model of the "stunned myocardium".
    Przyklenk K; Kloner RA
    Circ Res; 1986 Jan; 58(1):148-56. PubMed ID: 3943152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion.
    Kingma JG; Plante S; Bogaty P
    J Am Coll Cardiol; 2000 Dec; 36(7):2317-24. PubMed ID: 11127479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of coronary venous retroinfusion of superoxide dismutase and catalase on reperfusion arrhythmias, myocardial function, and infarct size in dogs.
    Hatori N; Miyazaki A; Tadokoro H; Rydén L; Moll J; Rajagopalan RE; Fishbein MC; Meerbaum S; Corday E; Drury JK
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):396-404. PubMed ID: 2476618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury.
    Ambrosio G; Becker LC; Hutchins GM; Weisman HF; Weisfeldt ML
    Circulation; 1986 Dec; 74(6):1424-33. PubMed ID: 3779923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled reperfusion after myocardial ischemia in a canine model monitored by two-dimensional phosphorus 31 chemical shift spectroscopic imaging.
    Campbell CM; Wisenberg G; Sykes J; Thompson RT
    Am Heart J; 1997 May; 133(5):508-16. PubMed ID: 9141372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels.
    Kersten JR; Schmeling TJ; Hettrick DA; Pagel PS; Gross GJ; Warltier DC
    Anesthesiology; 1996 Oct; 85(4):794-807; discussion 27A. PubMed ID: 8873550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.